Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.

March
SunMonTueWedThuFriSat
2324252627281234567891011121314151617181920212223242526272829303112345
March
SunMonTueWedThuFriSat
2324252627281234567891011121314151617181920212223242526272829303112345
Copyright © Ark Medical Solutions Inc. All Rights Reserved.